Table of Contents 3
List of Tables 4
List of Figures 4
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oragenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oragenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Oragenics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Intrexon Enters into Co-Development Agreement with Oragenics 10
Licensing Agreements 11
Oragenics Enters Into Licensing Agreement With Intrexon For Lantibiotics 11
Equity Offering 13
Oragenics Raises USD13.8 Million Public Offering of Shares and Warrants 13
Oragenics Prices Private Placement of Shares for USD1.8 Million 15
Oragenics Raises USD3.3 Million in Rights Offering of Preferred Shares 16
Oragenics Raises USD6.7 Million in Private Placement of Shares 17
Oragenics Raises USD1.7 Million in Second Tranche of Private Placement of Series A Preferred Stock 18
Oragenics Raises USD1.3 Million in First Tranche of Private Placement of Series A Preferred Stock 19
Oragenics Raises USD4.7 Million in Private Placement of Shares 20
Oragenics Completes Public Offering Of Shares For US$11 Million 22
Oragenics Completes Private Placement Of Shares For US$4 Million 23
Oragenics Completes Private Placement Of Common Stock For US$13 Million 24
Asset Transactions 25
Oragenics Sells Certain Probiotic Business Assets to ProBiora Health 25
Oragenics Inc - Key Competitors 26
Oragenics Inc - Key Employees 27
Oragenics Inc - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Apr 18, 2017: Oragenics Provides First Quarter 2017 Update 29
Product News 30
06/06/2017: Oragenics Presents Development of Novel Lantibiotic Against Clostridium difficile at the ICAAC Conference 30
03/19/2018: Oragenics Announces Peer Reviewed Publication Examining Efficacy of Mutacin 1140 Lantibiotic Variants against Clostridium difficile 31
Clinical Trials 32
Mar 23, 2018: Oragenics Completes Enrollment for the Interim Analysis Cohort in Its Phase 2 Clinical Trial of AG013 for Oral Mucositis 32
Aug 31, 2017: Oragenics Doses First Patient in Phase 2 Clinical Trial of AG013 for Oral Mucositis 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Oragenics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oragenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oragenics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Oragenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intrexon Enters into Co-Development Agreement with Oragenics 10
Oragenics Enters Into Licensing Agreement With Intrexon For Lantibiotics 11
Oragenics Raises USD13.8 Million Public Offering of Shares and Warrants 13
Oragenics Prices Private Placement of Shares for USD1.8 Million 15
Oragenics Raises USD3.3 Million in Rights Offering of Preferred Shares 16
Oragenics Raises USD6.7 Million in Private Placement of Shares 17
Oragenics Raises USD1.7 Million in Second Tranche of Private Placement of Series A Preferred Stock 18
Oragenics Raises USD1.3 Million in First Tranche of Private Placement of Series A Preferred Stock 19
Oragenics Raises USD4.7 Million in Private Placement of Shares 20
Oragenics Completes Public Offering Of Shares For US$11 Million 22
Oragenics Completes Private Placement Of Shares For US$4 Million 23
Oragenics Completes Private Placement Of Common Stock For US$13 Million 24
Oragenics Sells Certain Probiotic Business Assets to ProBiora Health 25
Oragenics Inc, Key Competitors 26
Oragenics Inc, Key Employees 27
Oragenics Inc, Other Locations 28

List of Figures
Oragenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oragenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8